Hypothyroidism M21-341 AVANTI
Study details
View study details on clinicaltrials.gov.
Locations
- Burlingame
Clinical trial FAQs
Information for patients and study volunteers, including frequently asked questions.
This study will evaluate the efficacy and safety of Armour Thyroid treatment compared with synthetic T4 in subjects who have primary hypothyroidism and are currently stabilized (i.e., in-range thyroid-stimulating hormone [TSH]) on synthetic T4 treatment. This study will also therefore evaluate the efficacy and safety of dose conversion from synthetic T4 therapy to Armour Thyroid therapy.
Email us to enroll
Related clinical trials
View all clinical trials- Clinical trial
Congenital Adrenal Hyperplasia in Pediatrics CRN04894-13
A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Atumelnant Treatment in Pediatric Participants With Congenital Adrenal Hyperplasia Including a Long-Term Extension
Status: Coming Soon
- Clinical trial
Idiopathic Short Stature 111-210
A Phase 2, Randomized, Controlled, Multicenter Study of Vosoritide in Children With Idiopathic Short Stature
Status: Closed to Enrollment
- Clinical trial
Diabetes Type II Pediatric ACHIEVE-PEDS J2A-MC-GZGY
A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Once-Daily Oral Orforglipron Compared With Once-Weekly Dulaglutide in Pediatric Participants 10 to Less Than 18 Years of Age With Type 2 Diabetes
Status: Coming Soon
- Clinical trial
Growth Hormone Deficiency (GHD) LUM-201-10 OraGrowth
A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Open to Enrollment
- Clinical trial
Idiopathic Short Stature ASND0047 HighLiGHts
A Pivotal, Parallel-Arm, Phase 3, Open-Label, Active-controlled, Global, Multicenter, Randomized Basket Trial Investigating the Efficacy and Safety of Once-weekly Lonapegsomatropin Compared to Daily Somatropin in Prepubertal Children and Adolescents With Growth Failure or Short Stature Due to Growth Hormone Sufficient Disorders - Turner Syndrome, SHOX Deficiency, Small for Gestational Age, and Idiopathic Short Stature
Status: Open to Enrollment